SNTI
- Senti Biosciences, Inc.
()
Overview
Company Summary
Senti Biosciences, Inc. is a biotechnology company focused on developing precision gene circuit technologies for various applications in healthcare. Specifically, they specialize in developing synthetic gene circuits to enable precise control of cellular behavior, allowing for targeted gene editing and therapy.
Their flagship technology is called "Gene Circuit Technology," which combines synthetic biology, gene editing tools, and machine learning algorithms to engineer precise gene circuits capable of regulating cellular functions. Using this technology, Senti Biosciences aims to address challenging medical conditions such as cancer, genetic diseases, and autoimmune disorders.
The company's approach involves designing gene circuits that can sense specific cellular signals and respond with precise therapeutic actions. By integrating these circuits into living cells, they can modify the behavior of those cells to perform desired functions, such as selectively targeting and eliminating cancer cells or regulating immune responses.
Senti Biosciences leverages the power of advanced genetic engineering tools like CRISPR-Cas9 to enable precise editing and manipulation of genetic material within the gene circuits they design. They also utilize machine learning algorithms to optimize and predict the behavior of their gene circuits in complex cellular environments.
Ultimately, Senti Biosciences aims to revolutionize healthcare by providing novel gene therapies that offer precise control over cellular behavior, leading to more effective and targeted treatment options for patients.